Fatty liver study in Sohag University employees
Part of Digestive system clinical trials.
This study looks at a common condition called metabolic fatty liver disease in employees of Sohag University. It aims to find out how many employees have this condition and understand its link to health issues like diabetes and obesity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an employee of Sohag University.
- You must not have liver disease caused by medications or drugs.
- You must not have a chronic liver disease (like hepatitis or cirrhosis).
- You must not have severe liver cirrhosis with complications.
- You must not drink more than a moderate amount of alcohol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a registry of people whose belly ultrasound shows a fatty liver linked to metabolic problems (like weight, blood sugar, or cholesterol). It doesn't test new treatments but helps doctors learn more about this condition.
This study looks at how fat in the muscles may affect liver disease in people with fatty liver and related conditions like obesity or diabetes. It aims to better understand the connection between muscle fat and liver health.
This study classifies fatty liver disease (MAFLD) by examining liver tissue samples. It aims to better understand how metabolic risk factors like high blood sugar, high blood pressure, or excess weight relate to the liver's condition.
This research study looks at people with type 2 diabetes to learn more about fatty liver disease. By joining, you may help doctors better understand how these conditions are linked and improve future care.
This study uses ultrasound to look at the liver and help classify a type of fatty liver disease called MASLD. It may help doctors better understand and diagnose this condition.
This study tests whether a specially designed gut bacteria treatment can help people with fatty liver disease and related health issues like high blood sugar, high cholesterol, or high blood pressure. It aims to see if the treatment is safe and improves liver health.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.